|
🦁
|
Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)
12 auth.
V. Puntmann,
M. Carerj,
I. Wieters,
Masia Fahim,
C. Arendt,
Jedrzej Hoffmann,
...
Anastasia Shchendrygina,
F. Escher,
M. Vasa-Nicotera,
A. Zeiher,
M. Vehreschild,
E. Nagel
|
10 |
2020 |
10
🦁
|
|
🦁
|
Native T1 mapping in differentiation of normal myocardium from diffuse disease in hypertrophic and dilated cardiomyopathy.
11 auth.
V. Puntmann,
T. Voigt,
Zhong Chen,
M. Mayr,
R. Karim,
K. Rhode,
...
A. Pastor,
G. Carr-White,
R. Razavi,
T. Schaeffter,
E. Nagel
|
8 |
2013 |
8
🦁
|
|
🦁
|
T1-Mapping and Outcome in Nonischemic Cardiomyopathy: All-Cause Mortality and Heart Failure.
19 auth.
V. Puntmann,
G. Carr-White,
A. Jabbour,
Chung-yao Yu,
R. Gebker,
S. Kelle,
R. Hinojar,
A. Doltra,
N. Varma,
Nicholas M. Child,
...
T. Rogers,
G. Suna,
E. Arroyo Úcar,
Benjamin P Goodman,
Sitara G. Khan,
D. Dabir,
E. Herrmann,
A. Zeiher,
E. Nagel
|
8 |
2016 |
8
🦁
|
|
🐜
|
Magnetic Resonance Perfusion or Fractional Flow Reserve in Coronary Disease.
21 auth.
E. Nagel,
J. Greenwood,
G. Mccann,
N. Bettencourt,
A. Shah,
Shazia T. Hussain,
D. Perera,
S. Plein,
C. Bucciarelli-Ducci,
Matthias Paul,
...
M. Westwood,
M. Marber,
W. Richter,
V. Puntmann,
C. Schwenke,
J. Schulz-Menger,
R. Das,
J. Wong,
D. Hausenloy,
H. Steen,
C. Berry
|
8 |
2019 |
8
🐜
|
|
🐢
|
Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study
18 auth.
D. Dabir,
Nicholas M. Child,
A. Kalra,
T. Rogers,
R. Gebker,
A. Jabbour,
S. Plein,
Chung-yao Yu,
J. Otton,
A. Kidambi,
...
A. Mcdiarmid,
D. Broadbent,
D. Higgins,
B. Schnackenburg,
L. Foote,
C. Cummins,
E. Nagel,
V. Puntmann
|
8 |
2014 |
8
🐢
|
|
🐜
|
2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play
20 auth.
T. Gluckman,
N. Bhave,
L. Allen,
Eugene H. Chung,
E. Spatz,
E. Ammirati,
A. Baggish,
B. Bozkurt,
W. Cornwell,
K. Harmon,
...
Jonathan H. Kim,
A. Lala,
B. Levine,
Matthew W. Martinez,
O. Onuma,
D. Phelan,
V. Puntmann,
S. Rajpal,
P. Taub,
A. Verma
|
8 |
2022 |
8
🐜
|
|
🦁
|
T1 Mapping in Characterizing Myocardial Disease: A Comprehensive Review.
V. Puntmann,
E. Peker,
E. Peker,
Y. Chandrashekhar,
E. Nagel
|
7 |
2016 |
7
🦁
|
|
🐢
|
Native T1 in discrimination of acute and convalescent stages in patients with clinical diagnosis of myocarditis: a proposed diagnostic algorithm using CMR.
12 auth.
R. Hinojar,
L. Foote,
E. Arroyo Úcar,
Thomas Jackson,
A. Jabbour,
Chung-yao Yu,
...
J. McCrohon,
D. Higgins,
G. Carr-White,
M. Mayr,
E. Nagel,
V. Puntmann
|
7 |
2015 |
7
🐢
|
|
🐜
|
Proteomics Analysis of Cardiac Extracellular Matrix Remodeling in a Porcine Model of Ischemia/Reperfusion Injury
12 auth.
J. Barallobre-Barreiro,
A. Didangelos,
F. Schoendube,
I. Drozdov,
X. Yin,
M. Fernandez-Caggiano,
...
P. Willeit,
V. Puntmann,
G. Aldama-López,
A. Shah,
N. Domenech,
M. Mayr
|
7 |
2012 |
7
🐜
|
|
🦁
|
Native Myocardial T1 Mapping by Cardiovascular Magnetic Resonance Imaging in Subclinical Cardiomyopathy in Patients With Systemic Lupus Erythematosus
10 auth.
V. Puntmann,
D. D’Cruz,
Zachary Smith,
A. Pastor,
P. Choong,
T. Voigt,
...
G. Carr-White,
S. Sangle,
T. Schaeffter,
E. Nagel
|
7 |
2013 |
7
🦁
|
|
🐢
|
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
16 auth.
R. Hinojar,
N. Varma,
Nicholas M. Child,
Benjamin P Goodman,
A. Jabbour,
Chung-yao Yu,
R. Gebker,
A. Doltra,
S. Kelle,
Sitara G. Khan,
...
T. Rogers,
E. Arroyo Úcar,
C. Cummins,
G. Carr-White,
E. Nagel,
V. Puntmann
|
7 |
2015 |
7
🐢
|
|
🦁
|
How-to guide on biomarkers: biomarker definitions, validation and applications with examples from cardiovascular disease
V. Puntmann
|
7 |
2009 |
7
🦁
|
